Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges. [electronic resource]

By: Contributor(s): Producer: 20200305Description: 89-92 p. digitalISSN:
  • 1744-7658
Subject(s): Online resources: In: Expert opinion on investigational drugs vol. 29
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Editorial

There are no comments on this title.

to post a comment.